Winter Meeting

FDA – Safety Report

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering

FDA Drug Safety Communication

A safety announcement by the FDA on the dangers of rapid discontinuation of opioid medication with patients who are physically dependent.

Read the article here.


Please join us for an upcoming M&M style meeting where members will present details of difficult cases to a peer committee and receive feedback. These meetings are held every 4 months at Swedish Edmonds Hospital. Join our email list to receive event details or contact us to learn more.